In a surprising turn, Indian drugmakers' shares jumped 5% following the U.S. exempting pharmaceuticals from new tariffs. This decision could significantly boost India's pharma exports, which reached $9 billion last year.
President Trump is set to announce new tariffs on automobiles and pharmaceuticals soon, adding to his ongoing trade war strategy that includes steel and aluminum duties. This move signals a broader effort to reshape U.S. trade policies as April 2 approaches.
Eli Lilly to invest $27 billion in building new US manufacturing plants amid challenges from drug import duties. The move aligns with Trump's push for American manufacturing revitalization.